Filing search / Current reports / AbbVie Inc.

8-K

ABBV AbbVie Inc.

19 Feb 25

Other Events

9:22am

8-K

ABBV AbbVie Inc.

14 Feb 25

AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors

7:30am

8-K

ABBV AbbVie Inc.

5 Feb 25

Other Events

4:15pm

8-K

ABBV AbbVie Inc.

31 Jan 25

AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results

7:42am

8-K

ABBV AbbVie Inc.

10 Jan 25

Material Impairments

8:31am

8-K

3ya3c2w5o8xzv

6 Jan 25

Guidance Including the Impact of Acquired IPR&D and Milestones Expense

4:02pm

8-K

q5qg0zpoolo 6k

13 Dec 24

Departure of Directors or Certain Officers

4:05pm

8-K

su1968hnx8510rtenb6o

30 Oct 24

AbbVie Reports Third-Quarter 2024 Financial Results

7:43am

8-K

pdym6az i54f

3 Oct 24

Guidance Including the Impact of Acquired IPR&D and Milestones Expense

4:07pm

8-K

jslupeww

10 Sep 24

Amendments to Articles of Incorporation or Bylaws

3:30pm

8-K

g90jh593ov75mufy07

25 Jul 24

AbbVie Reports Second-Quarter 2024 Financial Results

7:41am

8-K

55ekitqejdlx7q3qd1f

3 Jul 24

Guidance Including the Impact of Acquired IPR&D and Milestones Expense

2:07pm

8-K/A

upsp5rs mddpoisz

8 May 24

Departure of Directors or Certain Officers

5:00pm

8-K

ec25wnvv8viqfl9q

26 Apr 24

AbbVie Reports First-Quarter 2024 Financial Results

7:43am

8-K

4p51ia

3 Apr 24

Guidance Including the Impact of Acquired IPR&D and Milestones Expense

4:06pm

8-K

40y9q zui0wjv756nepg

26 Feb 24

Other Events

5:08pm

8-K

0myygp4

20 Feb 24

AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer

9:00am

8-K

cjbgycpzb t2i4a1u8

12 Feb 24

AbbVie Completes Acquisition of ImmunoGen

7:49am

8-K

9sfmyqn8cu2547ra

2 Feb 24

AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results

7:51am

8-K

q2h0s zpf4

5 Jan 24

Guidance Including the Impact of Acquired IPR&D and Milestones Expense

4:03pm